Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurosci Lett ; 422(2): 119-22, 2007 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-17590511

RESUMO

Acute levodopa (LD) application and exercise release human growth hormone (GH). An earlier trial showed, that combined stimulus of exercise and LD administration is the best provocative test for GH response in healthy participants. Objective was to show this combined effect of LD application and exercise on GH response and to investigate the impact on LD metabolism in 20 previously treated patients with Parkinson's disease (PD). We measured GH- and LD plasma concentrations following soluble 200 mg LD/50 mg benserazide administration during endurance exercise and rest on two separate consecutive days. GH concentrations significantly increased on both days, but GH release was significantly delayed during rest. LD metabolism was not altered due to exercise in a clinical relevant manner. Exercise induced a significant faster LD stimulated GH release in comparison with the rest condition. We did not find the supposed increase of LD induced GH release by endurance exercise. We assume, that only a limited amount of GH is available for GH release in the anterior pituitary following an acute 200 mg LD administration. GH disposal also depends on growth hormone releasing hormone (GHRH), which is secreted into hypothalamic portal capillaries. During the exercise condition, the resulting higher blood pressure supports blood flow and thus GHRH transport towards the GH producing cells in the pituitary. This might additionally have caused the significant faster GH release during exercise.


Assuntos
Terapia por Exercício/métodos , Hormônio do Crescimento/metabolismo , Levodopa/farmacologia , Doença de Parkinson/fisiopatologia , Doença de Parkinson/terapia , Esforço Físico , Idoso , Antiparkinsonianos/farmacologia , Benserazida/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Circulação Cerebrovascular/efeitos dos fármacos , Sinergismo Farmacológico , Tolerância ao Exercício/efeitos dos fármacos , Feminino , Hormônio Liberador de Gonadotropina/metabolismo , Hormônio do Crescimento/sangue , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/metabolismo , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Levodopa/sangue , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/sangue , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA